Hunting for Antibodies Against COVID19: George Scangos on The Long Run

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

Medicines Based on Unusual Genetic Traits: Andrew Farnum on The Long Run
Creating the Future of Microbiome-Based Therapies: Simba Gill on The Long Run
The Battle for the Soul of Biopharma: Peter Kolchinsky on The Long Run
Machine Learning for Drug Discovery: Daphne Koller on The Long Run